Deliriz I.V Injection
Marketer
Insutik pharmaceuticals Private Limited
Salt Composition
Pantoprazole (40mg)
Overview Deliriz I.V Injection
GastriCalm IV Injection diminishes gastric acid production. It treats acid-related gastrointestinal conditions including gastroesophageal reflux disease, peptic ulcers, and Zollinger-Ellison syndrome, offering symptom relief and facilitating healing. GastriCalm IV Injection also prevents stress ulcers in critically ill patients and is pre-operatively administered to mitigate aspiration risks. Classified as a proton pump inhibitor (PPI), this intravenous injection is solely administered by a healthcare professional when deemed superior to oral medication. Dosage and treatment duration are determined by your physician based on your condition and response. Consistent use as prescribed is crucial, even with rapid symptom improvement. Dietary modifications – smaller, more frequent meals, avoidance of caffeine, spicy, and fatty foods – can enhance treatment efficacy. Common, generally mild, side effects include nausea, vomiting, headache, dizziness, gas, diarrhea, abdominal pain, and thrombophlebitis (vein inflammation). Persistent or bothersome side effects warrant medical attention. Prolonged use (over one year) may elevate the risk of bone fractures, particularly at higher doses; discuss bone health preservation strategies, such as calcium and vitamin D supplementation, with your doctor. GastriCalm IV Injection is contraindicated for individuals with severe hepatic impairment, those on HIV medications, those with a history of PPI allergy, or existing osteoporosis. Pregnant or lactating women should seek medical counsel prior to use. Alcohol consumption should be avoided due to its acid-stimulating effects. Refrain from operating machinery if dizziness or drowsiness occurs.
Uses of Deliriz I.V Injection
Managing gastroesophageal reflux, peptic ulcers, and Zollinger-Ellison syndrome.
Major Benefits of Deliriz I.V Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Deliriz I.V Injection:
- Diarrhea
- Flatulence
- Headache
- Joint pain
- Nausea
- Stomach pain
- Vomiting
- Dizziness
- Thrombophlebitis
How to use Deliriz I.V Injection:
This medication will be administered by your physician or their designated nursing staff; self-medication is strictly prohibited.
How Deliriz I.V Injection works:
Gastro-acid suppression is achieved by Deliriz I.V Injection, a proton pump inhibitor that diminishes gastric acid production, thereby alleviating heartburn and acid indigestion.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption alongside Deliriz I.V. Injection is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Administering Deliriz I.V. Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescription. Patient consultation with their doctor is advised.
Breast feedingSAFE IF PRESCRIBED
Intravenous Deliriz administration appears safe for breastfeeding mothers. Available human data indicates minimal risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Deliriz I.V. Injection on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
For patients with kidney impairment, Deliriz I.V Injection is considered safe and requires no dosage modification.
LiverCAUTION
For patients exhibiting severe hepatic impairment, intravenous Deliriz administration requires careful consideration. Dosage modification of Deliriz I.V Injection may be necessary. Physician consultation is advised.
What if you forget to take Deliriz I.V Injection :
Omitting a scheduled dose of Deliriz I.V. Injection necessitates contacting your physician.
Facts to Know About Deliriz I.V Injection
| Label | Value |
|---|---|
| Chemical Category | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Type of Treatment | Gastrointestinal system |
| Behavior Class | Gastric acid suppressants |



